# Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy Subjects

> **NCT00942240** · PHASE1 · COMPLETED · sponsor: **Kubota Vision Inc.** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ACU-4429
- **DRUG:** matching placebo tablet

## Key facts

- **NCT ID:** NCT00942240
- **Lead sponsor:** Kubota Vision Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00942240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00942240, "Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00942240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*